Abstract
The aim of this prospective study was to determine if sacral neuromodulation has an effect on the patient’s subsequent sexual function. Sexually active patients that underwent an Interstim® Sacroneuromodulator implantation (Medtronic, Minneapolis, MN) for control of bladder symptoms were enrolled. A Female Sexual Function Index (FSFI) was completed before surgery and at a mean of 5.7 months postoperatively. Eleven subjects proceeded to permanent implantation, seven of these were sexually active before and after placement. Three subjects (43%) felt the device impacted on their sexual function in a positive way (1) by decreasing urgency and (2) by increasing desire. Overall sexual frequency increased significantly after the surgery (p=0.047). There were also significant increases in the FSFI total (p=0.002), and domain scores for desire (p=0.004), lubrication (p=0.005), orgasm (p=0.043), satisfaction (p=0.007), and pain (p=0.015). There was no correlation between patient report of urinary symptom improvement and FSFI scores. In conclusion, sacral neuromodulation may improve sexual frequency and sexual function scores in subjects with urgency frequency and urge incontinence.
Similar content being viewed by others
References
Leng WW, Chancellor MB (2005) How sacral nerve stimulation neuromodulation works. Urol Clin North Am 32(1):11–18
Bernstein AJ, Peters KM (2005) Expanding indications for neuromodulation. Urol Clin North Am 32(1):59–63
Jarrett ME, Nicholls RJ, Kamm MA (2005) Effect of sacral neuromodulation for faecal incontinence on sexual activity. Colorectal Dis 7(5):523–525
Meston CM (2003) Validation of the Female Sexual Function Index (FSFI) in women with female orgasmic disorder and in women with hypoactive sexual desire disorder. J Sex Marital Ther 29(1):39–46
Rosen R, Brown C, Heiman J, Leiblum S, Meston C, Shabsigh R et al (2000) The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther 26(2):191–208
McKenna KE (2002) The neurophysiology of female sexual function. World J Urol 20(2):93–100
O’Connell HE, Sanjeevan KV, Hutson JM (2005) Anatomy of the clitoris. J Urol 174(4 Pt 1):1189–1195
Basson R, McInnes R, Smith MD, Hodgson G, Koppiker N (2002) Efficacy and safety of sildenafil citrate in women with sexual dysfunction associated with female sexual arousal disorder. J Womens Health Gend Based Med 11(4):367–377
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Pauls, R.N., Marinkovic, S.P., Silva, W.A. et al. Effects of sacral neuromodulation on female sexual function. Int Urogynecol J 18, 391–395 (2007). https://doi.org/10.1007/s00192-006-0168-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00192-006-0168-9